Published in Eur Respir J on May 01, 1996
Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol (2001) 3.56
Epidemiology of tuberculosis in Hamburg, Germany: long-term population-based analysis applying classical and molecular epidemiological techniques. J Clin Microbiol (2002) 2.03
European union standards for tuberculosis care. Eur Respir J (2012) 1.73
Imaging bacterial infection with (99m)Tc-ciprofloxacin (Infecton). J Clin Pathol (2002) 1.27
Assessing the validity of tuberculosis surveillance data in California. BMC Public Health (2006) 1.13
Tracking a tuberculosis outbreak over 21 years: strain-specific single-nucleotide polymorphism typing combined with targeted whole-genome sequencing. J Infect Dis (2014) 1.01
Tuberculosis treatment outcome monitoring in European Union countries: systematic review. Eur Respir J (2012) 0.91
Tuberculosis in HIV-negative and HIV-infected patients in a low-incidence country: clinical characteristics and treatment outcomes. PLoS One (2012) 0.91
Immune responses to ESAT-6 and CFP-10 by FASCIA and multiplex technology for diagnosis of M. tuberculosis infection; IP-10 is a promising marker. PLoS One (2012) 0.86
High rates of Mycobacterium tuberculosis among socially marginalized immigrants in low-incidence area, 1991-2010, Italy. Emerg Infect Dis (2013) 0.84
Diagnostic accuracy of notified cases as pulmonary tuberculosis in private sectors of Korea. J Korean Med Sci (2012) 0.82
Impact of immigration and HIV infection on tuberculosis incidence in an area of low tuberculosis prevalence. Epidemiol Infect (2006) 0.81
Microbiological confirmation of tuberculosis cases at diagnosis and at the end of treatment in Italy. Eur J Epidemiol (2000) 0.77
Epidemiology of childhood tuberculosis in Switzerland between 1996 and 2011. Eur J Pediatr (2013) 0.77
Improved bacteriological data are needed to give uniform reporting of tuberculosis in Europe. BMJ (1998) 0.75
Notification of tuberculosis in a university hospital. Eur J Epidemiol (1998) 0.75
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82
Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (1998) 10.78
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J (2011) 8.96
Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA (2000) 8.42
Tuberculosis in Britain today. BMJ (1993) 6.17
Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ (1994) 6.11
Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med (2001) 6.05
Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis (1998) 5.51
Interferon-γ release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis. Eur Respir J (2010) 4.72
"Heartstart Scotland"--initial experience of a national scheme for out of hospital defibrillation. BMJ (1991) 4.56
Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis (1997) 4.02
HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tuber Lung Dis (1992) 3.95
Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J (2010) 3.81
RhoA is required for monocyte tail retraction during transendothelial migration. J Cell Biol (2001) 3.79
125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR-TB threat. Is "science" enough to tackle the epidemic? Eur Respir J (2007) 3.67
"Doctors' orders": controlled trial of supplementary, written information for patients. Br Med J (1979) 3.65
Determinants of drug-resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis (2001) 3.51
Screening migrants at risk of tuberculosis. BMJ (1993) 3.34
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement. Eur Respir J (2009) 3.16
Public health. Responding to market failures in tuberculosis control. Science (2001) 3.12
Factors that determine false recall: a multiple regression analysis. Psychon Bull Rev (2001) 3.08
Socioeconomic deprivation and notification rates for tuberculosis in London during 1982-91. BMJ (1995) 3.06
Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998. Thorax (2001) 3.01
The value of contact procedures for tuberculosis in Edinburgh. Br J Dis Chest (1984) 2.82
Outbreak of isoniazid resistant tuberculosis in north London. Thorax (2004) 2.82
Evidence for genetic exchange and recombination of Rhizobium symbiotic plasmids in a soil population. Appl Environ Microbiol (1987) 2.76
DNA sequence of Rhizobium trifolii nodulation genes reveals a reiterated and potentially regulatory sequence preceding nodABC and nodFE. Nucleic Acids Res (1986) 2.68
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J (2010) 2.56
Clinical and operational value of the extensively drug-resistant tuberculosis definition. Eur Respir J (2007) 2.46
Lung function and long term exposure to air pollutants in Switzerland. Study on Air Pollution and Lung Diseases in Adults (SAPALDIA) Team. Am J Respir Crit Care Med (1997) 2.45
Genetic and molecular characterization of the Pseudomonas plasmid pVS1. Plasmid (1984) 2.44
Virological analysis of fatal influenza cases in the United Kingdom during the early wave of influenza in winter 2010/11. Euro Surveill (2011) 2.40
[Comparative study of topical treatment of seasonal allergic rhinitis with aqueous beclomethasone and flunisolide]. Ther Umsch (1984) 2.39
Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ (2000) 2.38
Chromosome mapping in Pseudomonas aeruginosa PAT. J Bacteriol (1978) 2.38
Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J (2010) 2.38
The current value of tuberculin testing and BCG vaccination in school children. Br J Dis Chest (1986) 2.32
Heterogeneous case definitions used for the surveillance of influenza in Europe. Eur J Epidemiol (2003) 2.20
Notification of tuberculosis: can the pathologist help? BMJ (1988) 2.19
The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis. Thorax (1978) 2.19
Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients. Int J Tuberc Lung Dis (2014) 2.18
Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men. Br Med J (1976) 2.16
BCG immunisation in England and Wales: a survey of policy and practice in schoolchildren and neonates. BMJ (1992) 2.13
Antibiotic resistant tuberculosis in the United Kingdom: 1993-1999. Thorax (2002) 2.12
Risk factors for tuberculosis in HIV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA (1995) 2.08
Outbreak of low pathogenicity H7N3 avian influenza in UK, including associated case of human conjunctivitis. Euro Surveill (2006) 2.08
Effectiveness of rifampin, rifabutin, and rifapentine for preventive therapy of tuberculosis in mice. Am Rev Respir Dis (1993) 2.07
Tuberculosis control in Europe and international migration. Eur Respir J (1994) 2.07
Effect of oral salbutamol and slow-release aminophylline on exercise tolerance in chronic bronchitis. Thorax (1981) 2.06
Cost-effectiveness analysis of invasive and noninvasive tests in high risk patients treated with amiodarone after acute myocardial infarction. J Am Coll Cardiol (1998) 2.02
Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J (2009) 2.01
Active case finding for pulmonary tuberculosis using mobile digital chest radiography: an observational study. Int J Tuberc Lung Dis (2012) 2.00
Prevalence, morbidity and service need among South Asian and white adults with intellectual disability in Leicestershire, UK. J Intellect Disabil Res (2002) 1.98
Impact of BCG on tuberculous meningitis in France in 1990. Lancet (1992) 1.97
Epidemiology and control of tuberculosis in Western European cities. Int J Tuberc Lung Dis (2003) 1.95
Tuberculosis among the homeless at a temporary shelter in London: report of a chest x ray screening programme. J Epidemiol Community Health (1995) 1.91
A G protein-coupled receptor for UDP-glucose. J Biol Chem (2000) 1.91
Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project. Int J Tuberc Lung Dis (1999) 1.90
SAPALDIA: methods and participation in the cross-sectional part of the Swiss Study on Air Pollution and Lung Diseases in Adults. Soz Praventivmed (1997) 1.88
Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy. Int J Tuberc Lung Dis (2002) 1.86
Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective. Thorax (2007) 1.86
Suppressor mutations in Pseudomonas aeruginosa. J Bacteriol (1976) 1.81
Sputum smear conversion during directly observed treatment for tuberculosis. Tuber Lung Dis (1996) 1.76
European union standards for tuberculosis care. Eur Respir J (2012) 1.73
Drug-resistant tuberculosis: laboratory issues. World Health Organization recommendations. Tuber Lung Dis (1994) 1.71
Effects of leukotriene D on the airways in asthma. N Engl J Med (1983) 1.69
The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Euro Surveill (2012) 1.67
Solvent encephalopathy. Br Med J (Clin Res Ed) (1981) 1.66
Long-term ambient air pollution and respiratory symptoms in adults (SAPALDIA study). The SAPALDIA Team. Am J Respir Crit Care Med (1999) 1.65
Mycobacterium bovis in England and Wales: past, present and future. Epidemiol Infect (1992) 1.64
Abuse of solvents "for kicks". A review of 50 cases. Lancet (1977) 1.62
Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill (2011) 1.61
High risk of tuberculosis in health care workers in Romania. Int J Tuberc Lung Dis (2008) 1.60
Cost-effectiveness of treating latent tuberculous infection: a step towards elimination? Int J Tuberc Lung Dis (2013) 1.58
Comparison of two methods of processing induced sputum: selected versus entire sputum. Am J Respir Crit Care Med (1998) 1.56
Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res (2006) 1.54
Impact of the HIV epidemic on the spread of other diseases: the case of tuberculosis. AIDS (2000) 1.52
Notification of tuberculosis: an updated code of practice for England and Wales. J R Coll Physicians Lond (1997) 1.52
The impact of immigration on tuberculosis rates in the United Kingdom compared with other European countries. Int J Tuberc Lung Dis (2009) 1.50
Evaluating functional MRI procedures for assessing hemispheric language dominance in neurosurgical patients. Neuroradiology (2005) 1.49
Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS (1995) 1.48
[Guidelines for drug treatment of tuberculosis in adults and childhood]. Pneumologie (2001) 1.47
Standardization of antituberculosis drug resistance surveillance in Europe. Recommendations of a World Health Organization (WHO) and International Union Against Tuberculosis and Lung Disease (IUATLD) Working Group. Eur Respir J (2000) 1.45
Optimal duration of radiological follow-up for tuberculosis contacts. Respir Med (1989) 1.45
Audit of procedures related to outcome of chest clinic consultation. Respir Med (1994) 1.45